Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2008-10-29 14:53:30 UTC |
---|
Update Date | 2022-11-30 19:03:55 UTC |
---|
HMDB ID | HMDB0011154 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | LysoPA(P-16:0/0:0) |
---|
Description | 1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. 1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is irreversibly produced from 1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine via the enzyme alkylglycerophosphoethanolamine phosphodiesterase (EC: 3.1.4.39). Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. |
---|
Structure | [H][C@@](O)(CO\C=C/CCCCCCCCCCCCCC)COP(O)(O)=O InChI=1S/C19H39O6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-24-17-19(20)18-25-26(21,22)23/h15-16,19-20H,2-14,17-18H2,1H3,(H2,21,22,23)/b16-15-/t19-/m1/s1 |
---|
Synonyms | Value | Source |
---|
1-(1Z-Hexadecenyl)-sn-glycero-3-phosphate | HMDB | 1-(1Z-Hexadecenyl)-glycero-3-phosphate | HMDB | 1-(1Z-Hexadecenyl)-lysophosphatidic acid | HMDB | LPA(16:1) | HMDB | LPA(p-16:0) | HMDB | LPA(p-16:0/0:0) | HMDB | LysoPA(16:1) | HMDB | LysoPA(p-16:0) | HMDB | Lysophosphatidic acid(16:1) | HMDB | Lysophosphatidic acid(p-16:0) | HMDB | Lysophosphatidic acid(p-16:0/0:0) | HMDB | LPA(O-16:1(1Z)) | HMDB | LPA(O-16:1(1Z)/0:0) | HMDB | LysoPA(O-16:1(1Z)) | HMDB | LysoPA(O-16:1(1Z)/0:0) | HMDB | Lysophosphatidic acid(O-16:1(1Z)) | HMDB | Lysophosphatidic acid(O-16:1(1Z)/0:0) | HMDB | LysoPA(P-16:0/0:0) | HMDB |
|
---|
Chemical Formula | C19H39O6P |
---|
Average Molecular Weight | 394.4831 |
---|
Monoisotopic Molecular Weight | 394.248425492 |
---|
IUPAC Name | [(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-hydroxypropoxy]phosphonic acid |
---|
Traditional Name | (2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-hydroxypropoxyphosphonic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCCCCCCCCCCC\C=C/OC[C@](O)([H])COP(=O)(O)O |
---|
InChI Identifier | InChI=1S/C19H39O6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-24-17-19(20)18-25-26(21,22)23/h15-16,19-20H,2-14,17-18H2,1H3,(H2,21,22,23)/b16-15-/t19-/m1/s1 |
---|
InChI Key | LBGSRVIXIVDRQM-OAXWQBPPSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as glycerophosphates. Glycerophosphates are compounds containing a glycerol linked to a phosphate group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerophospholipids |
---|
Sub Class | Glycerophosphates |
---|
Direct Parent | Glycerophosphates |
---|
Alternative Parents | |
---|
Substituents | - Sn-glycerol-3-phosphate
- Glycerol vinyl ether
- Monoalkyl phosphate
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Secondary alcohol
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
LysoPA(P-16:0/0:0),1TMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O)O[Si](C)(C)C | 3011.1 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),1TMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O)O[Si](C)(C)C | 2990.2 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O[Si](C)(C)C)O[Si](C)(C)C | 2997.6 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O[Si](C)(C)C)O[Si](C)(C)C | 2822.9 | Standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O[Si](C)(C)C)O[Si](C)(C)C | 3496.2 | Standard polar | 33892256 | LysoPA(P-16:0/0:0),2TMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2980.4 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2835.6 | Standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 3221.6 | Standard polar | 33892256 | LysoPA(P-16:0/0:0),3TMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C | 2989.5 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),3TMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C | 2859.7 | Standard non polar | 33892256 | LysoPA(P-16:0/0:0),3TMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C | 3015.0 | Standard polar | 33892256 | LysoPA(P-16:0/0:0),1TBDMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O)O[Si](C)(C)C(C)(C)C | 3240.8 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),1TBDMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 3208.2 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TBDMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3442.3 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TBDMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3138.3 | Standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TBDMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3553.2 | Standard polar | 33892256 | LysoPA(P-16:0/0:0),2TBDMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3423.6 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TBDMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3122.8 | Standard non polar | 33892256 | LysoPA(P-16:0/0:0),2TBDMS,isomer #2 | CCCCCCCCCCCCCC/C=C\OC[C@@H](O)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3358.9 | Standard polar | 33892256 | LysoPA(P-16:0/0:0),3TBDMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3661.2 | Semi standard non polar | 33892256 | LysoPA(P-16:0/0:0),3TBDMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3271.3 | Standard non polar | 33892256 | LysoPA(P-16:0/0:0),3TBDMS,isomer #1 | CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3213.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - LysoPA(P-16:0/0:0) GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-9531000000-ecf25e4b5c790c3b72ed | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - LysoPA(P-16:0/0:0) GC-MS (1 TMS) - 70eV, Positive | splash10-01ot-9311000000-0e2b0f3208ece9cd4b07 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - LysoPA(P-16:0/0:0) GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 10V, Positive-QTOF | splash10-0002-2289000000-b39c890fd77227f34b03 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 20V, Positive-QTOF | splash10-006t-7491000000-0ccf378d516936664e60 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 40V, Positive-QTOF | splash10-00di-8890000000-51c67ab4219e365f3eba | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 10V, Negative-QTOF | splash10-002f-7239000000-c4129fe844e80844198b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 20V, Negative-QTOF | splash10-004i-9010000000-5d851393b928afd40d41 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 40V, Negative-QTOF | splash10-004i-9000000000-9acf499bba340234a84d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 10V, Negative-QTOF | splash10-0006-1009000000-ff72002b3f2b1c18ed44 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 20V, Negative-QTOF | splash10-004i-9001000000-bc8f7654f845648a306d | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 40V, Negative-QTOF | splash10-004i-9000000000-a5e502a2627af2048a1f | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 10V, Positive-QTOF | splash10-0002-3159000000-b84b2eb993b334f4b3d2 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 20V, Positive-QTOF | splash10-0002-8694000000-dfe7400fecee9e705ce1 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - LysoPA(P-16:0/0:0) 40V, Positive-QTOF | splash10-052b-9100000000-97ff4447b932b70a8b72 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
Disease References | Crohn's disease |
---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
| Iron deficiency |
---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
|
|
---|